Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID Vaccine for Indirect Protection in Hutterite Colonies
NCT04818736Phase 4Withdrawn
- Sponsor
- McMaster University
- Start
- Apr 2021
- Primary completion
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by McMaster University. Planned start Apr 2021; status: withdrawn.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04818736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818736.